Loading clinical trials...

Metoclopramide for Post-Traumatic Headache. A Pilot Study | Clinical Trials | Clareo Health

COMPLETEDPHASE1/PHASE2

Metoclopramide for Post-Traumatic Headache. A Pilot Study

NCT03056352•Montefiore Medical Center

Summary

Post-traumatic headache is common. We are determining short and longer-term outcomes among patients treated for post-traumatic headache with IV metoclopramide.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Traumatic injury to the head has occurred
•Headache has developed within 7 days of injury to the head
•Headache is not better accounted for by another diagnosis (eg, previous history of migraine or tension-type headache)
•The headache must be rated as moderate or severe in intensity at the time of initial evaluation.
•The plan of the attending emergency physician must include treatment with parenteral metoclopramide.

Exclusion Criteria

•Patients will be excluded if more than ten days have elapsed since the head trauma, if the headache has already been treated with an anti-dopaminergic medication, or for medication contra-indications including pheochromocytoma, seizure disorder, Parkinson's disease, use of monoamine oxidase inhibitors, and use of anti-rejection transplant medications. Patients will not be excluded for pregnancy or breast-feeding.

Locations (1)

Montefiore Medical Center

The Bronx, New York, United States

Key Dates

Start Date

March 1, 2017

Primary Completion Date

July 20, 2017

Completion Date

August 15, 2017

Last Updated

July 31, 2018

Enrollment

ACTUAL participants

Conditions

Post-Traumatic Headache

Interventions

Metoclopramide

DRUG

Diphenhydramine

DRUG

Exercise in Postconcussion Symptoms and Posttraumatic Headache

NCT06015451

Brain ConcussionPost-Concussion Syndrome+2 more

View study

COMPLETEDNA

Acupuncture in Traumatic Brain Injury

NCT04369911

Chronic Post-traumatic HeadacheMild Traumatic Brain Injury

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 31, 2018Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Metoclopramide for Post-Traumatic Headache. A Pilot Study

Inclusion Criteria

Exclusion Criteria

Exercise in Postconcussion Symptoms and Posttraumatic Headache

Acupuncture in Traumatic Brain Injury

Amitriptyline to Prevent Headache After Traumatic Brain Injury

Hypersensitivity to Phosphodiesterase 5 Inhibition in Post-Traumatic Headache

TBI Care: Collaborative Care for Pain After Traumatic Brain Injury (TBI)

Hypersensitivity to Opening of BKCa Channels in Post-Traumatic Headache